The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with Non-Transfusion-Dependent Thalassemia-Reference-Cited by-同舟云学术

The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with Non-Transfusion-Dependent Thalassemia

Published:2016-03 Issue: Volume:57 Page:97-99
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Ricchi Paolo,Costantini Silvia,Spasiano Anna,De Dominicis Gianfranco,Di Matola Tiziana,Cinque Patrizia,Ammirabile Massimiliano,Marsella Maria,Filosa Aldo

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference13 articles.

1. Non-transfusion-dependent thalassemias;Musallam;Haematologica,2013

2. Thalassemia intermedia today: should patients regularly receive transfusions?;Aessopos;Transfusion,2007

3. When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia;Taher;Vox Sang.,2015

4. Thalidomide therapy in a patient with thalassemia major;Aguilar-Lopez;Blood Cells Mol. Dis.,2008

5. Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy;Masera;Blood Transfus.,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide;American Journal of Hematology;2023-12-26

2. Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?;Diseases;2023-11-06

3. Safety and Efficacy of Thalidomide and Hydroxyurea Combination in Beta Thalassemia Patients;Indian Journal of Hematology and Blood Transfusion;2022-04-21

4. The use of hydroxyurea in the real life of MIOT network: an observational study;Expert Opinion on Drug Safety;2022-04-17

5. Efficacy and Safety of Thalidomide in Patients With Transfusion-Dependent Thalassemia;Indian Pediatrics;2021-07